1	US	us	NNP	_	2	nn	_
2	drugmaker	drugmaker	NN	p2=NNP	3	nn	_
3	Pfizer	pfizer	NNP	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	on	on	IN	_	4	prep	4:AM-TMP
6	Sunday	sunday	NNP	_	5	pobj	_
7	it	it	PRP	_	9	nsubj	9:A0=PAG
8	had	have	VBD	_	9	aux	_
9	raised	raise	VBN	pb=raise.01	4	ccomp	4:A1=PPT
10	its	its	PRP$	_	11	poss	_
11	offer	offer	NN	_	9	dobj	9:A1=PPT
12	for	for	IN	_	11	prep	_
13	British	british	JJ	_	14	amod	_
14	rival	rival	NN	p2=JJ	15	nn	_
15	AstraZeneca	astrazeneca	NNP	_	12	pobj	_
16	to	to	IN	_	9	prep	9:A4=GOL
17	69.3	0	CD	_	18	number	_
18	billion	#crd#	CD	_	19	num	_
19	pounds	pound	NNS	_	16	pobj	_
20	(	(	-LRB-	_	19	punct	_
21	$	$	$	_	23	quantmod	_
22	116.6	0	CD	_	23	number	_
23	billion	#crd#	CD	_	19	appos	_
24	)	)	-RRB-	_	19	punct	_
25	,	,	,	_	19	punct	_
26	or	or	CC	_	19	cc	_
27	55	0	CD	_	28	num	_
28	pounds	pound	NNS	_	19	conj	_
29	a	a	DT	_	30	det	_
30	share	share	NN	_	28	npadvmod	_
31	,	,	,	_	4	punct	_
32	and	and	CC	_	4	cc	_
33	would	would	MD	_	34	aux	34:AM-MOD
34	walk	walk	VB	pb=walk.01	4	conj	_
35	away	away	RB	_	34	advmod	34:AM-DIR
36	if	if	IN	_	40	mark	_
37	AstraZeneca	astrazeneca	NNP	_	40	nsubj	40:A0=PAG
38	did	do	VBD	_	40	aux	_
39	not	not	RB	_	40	neg	40:AM-NEG
40	accept	accept	VB	pb=accept.01	34	advcl	34:AM-ADV
41	it	it	PRP	_	40	dobj	40:A1=PPT
42	.	.	.	_	4	punct	_

1	But	but	CC	_	7	cc	7:AM-DIS
2	the	the	DT	_	4	det	_
3	latest	late	JJS	_	4	amod	_
4	bid	bid	NN	p2=VBN	7	nsubjpass	7:A1=PPT
5	was	be	VBD	_	7	auxpass	_
6	still	still	RB	_	7	advmod	7:AM-TMP
7	viewed	view	VBN	pb=view.02	0	root	_
8	as	as	IN	_	7	prep	7:A2=PRD
9	falling	fall	VBG	pb=fall.01	8	pcomp	_
10	short	short	JJ	p2=RB	9	oprd	9:A4=GOL
11	of	of	IN	_	10	prep	_
12	properly	properly	RB	_	13	advmod	13:AM-MNR
13	valuing	value	VBG	pb=value.01	11	pcomp	_
14	AstraZeneca	astrazeneca	NNP	_	13	dobj	13:A1
15	and	and	CC	_	7	cc	_
16	the	the	DT	_	17	det	_
17	company	company	NN	_	18	nsubj	22:A0=PAG;18:A1=PPT
18	is	be	VBZ	pb=be.01	7	conj	_
19	likely	likely	JJ	_	18	acomp	18:A2=PRD
20	to	to	TO	_	22	aux	_
21	publicly	publicly	RB	_	22	advmod	22:AM-MNR
22	reject	reject	VB	pb=reject.01	19	xcomp	_
23	it	it	PRP	_	22	dobj	22:A1=PPT
24	as	as	RB	_	25	advmod	_
25	early	early	RB	_	22	advmod	22:AM-TMP
26	as	as	IN	_	25	prep	_
27	Monday	monday	NNP	_	26	pobj	_
28	,	,	,	_	18	punct	_
29	according	accord	VBG	_	18	prep	18:AM-ADV
30	to	to	IN	_	29	prep	_
31	the	the	DT	_	33	det	_
32	Financial	financial	NNP	_	33	nn	_
33	Times	times	NNP	p2=NNPS	30	pobj	36:A0=PAG
34	,	,	,	_	33	punct	_
35	which	which	WDT	_	36	nsubj	36:R-A0
36	cited	cite	VBD	pb=cite.01	33	rcmod	_
37	people	people	NNS	_	36	dobj	36:A1=PPT
38	familiar	familiar	JJ	_	37	amod	_
39	with	with	IN	_	38	prep	_
40	the	the	DT	_	41	det	_
41	matter	matter	NN	_	39	pobj	_
42	.	.	.	_	18	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0=PAG;4:A0=PAG
2	wants	want	VBZ	pb=want.01	0	root	_
3	to	to	TO	_	4	aux	_
4	create	create	VB	pb=create.01	2	xcomp	2:A1=PPT
5	the	the	DT	_	6	det	_
6	world	world	NN	_	10	poss	_
7	's	's	POS	_	6	possessive	_
8	largest	large	JJS	_	10	amod	_
9	drugs	drug	NNS	_	10	nn	_
10	company	company	NN	_	4	dobj	4:A1=PPT
11	,	,	,	_	4	punct	_
12	with	with	IN	_	4	prep	_
13	a	a	DT	_	14	det	_
14	headquarters	headquarters	NN	_	12	pobj	_
15	in	in	IN	_	14	prep	_
16	New	new	NNP	_	17	nn	_
17	York	york	NNP	_	15	pobj	_
18	but	but	CC	p2=IN	14	cc	_
19	a	a	DT	_	21	det	_
20	tax	tax	NN	_	21	nn	_
21	base	base	NN	_	14	conj	_
22	in	in	IN	_	21	prep	_
23	Britain	britain	NNP	_	22	pobj	29:AM-LOC
24	,	,	,	_	23	punct	_
25	where	where	WRB	_	29	advmod	29:R-AM-LOC
26	corporate	corporate	JJ	_	28	amod	_
27	tax	tax	NN	_	28	nn	_
28	rates	rate	NNS	_	29	nsubj	29:A1=PPT
29	are	be	VBP	pb=be.01	23	rcmod	_
30	lower	low	JJR	_	29	acomp	29:A2=PRD
31	than	than	IN	_	30	prep	_
32	in	in	IN	_	31	prep	_
33	the	the	DT	_	35	det	_
34	United	united	NNP	_	35	nn	_
35	States	states	NNP	_	32	pobj	_
36	.	.	.	_	2	punct	_

1	It	it	PRP	_	3	nsubj	3:A0=PAG
2	has	have	VBZ	_	3	aux	_
3	met	meet	VBN	pb=meet.01	0	root	_
4	entrenched	entrenched	JJ	_	5	amod	_
5	opposition	opposition	NN	_	3	dobj	3:A1=PPT
6	from	from	IN	_	5	prep	_
7	AstraZeneca	astrazeneca	NNP	_	6	pobj	_
8	,	,	,	_	5	punct	_
9	as	as	RB	_	11	advmod	_
10	well	well	RB	_	11	advmod	_
11	as	as	IN	_	5	cc	_
12	many	many	JJ	_	13	amod	_
13	politicians	politician	NNS	_	5	conj	_
14	and	and	CC	_	13	cc	_
15	scientists	scientist	NNS	_	13	conj	17:A0=PPT
16	who	who	WP	p2=VBP	17	nsubj	17:R-A0
17	fear	fear	VBP	pb=fear.01	15	rcmod	_
18	cuts	cut	NNS	_	17	dobj	17:A1=PAG
19	to	to	IN	_	17	prep	_
20	jobs	job	NNS	_	19	pobj	_
21	and	and	CC	_	20	cc	_
22	research	research	NN	_	20	conj	_
23	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	US	us	NNP	_	3	nn	_
3	group	group	NN	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	its	its	PRP$	_	7	poss	_
6	new	new	JJ	_	7	amod	_
7	offer	offer	NN	_	8	nsubj	8:A1=PPT;14:A1=PPT
8	was	be	VBD	pb=be.01	4	ccomp	4:A1=PPT
9	final	final	JJ	_	8	acomp	8:A2=PRD
10	and	and	CC	_	8	cc	_
11	could	could	MD	_	14	aux	14:AM-MOD
12	not	not	RB	_	14	neg	14:AM-NEG
13	be	be	VB	_	14	auxpass	_
14	increased	increase	VBN	pb=increase.01	8	conj	_
15	.	.	.	_	4	punct	_

1	It	it	PRP	_	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	it	it	PRP	_	6	nsubj	6:A0=PAG;17:A0=PAG
4	would	would	MD	_	6	aux	6:AM-MOD
5	not	not	RB	_	6	neg	6:AM-NEG
6	make	make	VB	pb=make.05	2	ccomp	2:A1=PPT
7	a	a	DT	_	9	det	_
8	hostile	hostile	JJ	_	9	amod	_
9	offer	offer	NN	_	6	dobj	6:AM-PRR
10	directly	directly	RB	_	6	advmod	6:AM-MNR
11	to	to	IN	p2=TO	6	prep	6:A2=DIR
12	AstraZeneca	astrazeneca	NNP	_	13	nn	_
13	shareholders	shareholder	NNS	_	11	pobj	_
14	and	and	CC	_	6	cc	_
15	would	would	MD	_	17	aux	17:AM-MOD
16	only	only	RB	_	17	advmod	17:AM-ADV
17	proceed	proceed	VB	pb=proceed.01	6	conj	_
18	with	with	IN	_	17	prep	17:A1=PPT
19	an	an	DT	_	20	det	_
20	offer	offer	NN	_	18	pobj	_
21	with	with	IN	_	20	prep	_
22	the	the	DT	_	23	det	_
23	recommendation	recommendation	NN	_	21	pobj	_
24	of	of	IN	_	23	prep	_
25	the	the	DT	_	27	det	_
26	AstraZeneca	astrazeneca	NNP	_	27	nn	_
27	board	board	NN	_	24	pobj	_
28	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	nsubj	3:A0=PAG
2	also	also	RB	_	3	advmod	3:AM-DIS
3	increased	increase	VBD	pb=increase.01	0	root	_
4	the	the	DT	_	6	det	_
5	cash	cash	NN	_	6	nn	_
6	element	element	NN	_	3	dobj	3:A1=PPT
7	in	in	IN	_	6	prep	_
8	its	its	PRP$	_	9	poss	_
9	offer	offer	NN	_	7	pobj	_
10	to	to	IN	_	3	prep	3:A4=GOL
11	45	0	CD	_	12	num	_
12	%	%	NN	_	10	pobj	_
13	,	,	,	_	3	punct	_
14	with	with	IN	_	17	mark	_
15	AstraZeneca	astrazeneca	NNP	p2=JJ	16	nn	_
16	shareholders	shareholder	NNS	_	17	nsubj	17:A0=PAG;19:A0=PAG
17	set	set	VBN	p2=VBP|pb=set.08	3	advcl	_
18	to	to	TO	_	19	aux	_
19	receive	receive	VB	pb=receive.01	17	xcomp	17:A1=PPT
20	1.747	0	CD	_	21	num	_
21	shares	share	NNS	_	19	dobj	19:A1=PPT
22	in	in	IN	_	19	prep	19:AM-LOC
23	the	the	DT	_	25	det	_
24	enlarged	enlarged	JJ	p2=VBN	25	amod	_
25	company	company	NN	_	22	pobj	_
26	for	for	IN	_	19	prep	19:A3
27	each	each	DT	_	26	pobj	_
28	of	of	IN	_	27	prep	_
29	their	their	PRP$	_	31	poss	_
30	AstraZeneca	astrazeneca	NNP	p2=JJ	31	nn	_
31	shares	share	NNS	_	28	pobj	_
32	and	and	CC	_	17	cc	_
33	24.76	0	CD	_	34	num	_
34	pounds	pound	NNS	_	17	conj	_
35	in	in	IN	_	34	prep	_
36	cash	cash	NN	_	35	pobj	_
37	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	new	new	JJ	_	3	amod	_
3	offer	offer	NN	_	4	nsubj	4:A0=PAG
4	represents	represent	VBZ	pb=represent.01	0	root	_
5	a	a	DT	_	8	det	_
6	15	0	CD	_	7	num	_
7	%	%	NN	_	8	nn	_
8	premium	premium	NN	_	4	dobj	4:A1=PPT
9	over	over	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	current	current	JJ	_	12	amod	_
12	value	value	NN	_	9	pobj	_
13	of	of	IN	_	12	prep	_
14	a	a	DT	_	20	det	_
15	cash	cash	NN	_	20	nn	_
16	-	-	HYPH	_	15	hyph	_
17	and	and	CC	_	15	cc	_
18	-	-	HYPH	_	19	hyph	_
19	share	share	NN	p2=VB	15	conj	_
20	approach	approach	NN	_	13	pobj	21:A1=PPT
21	made	make	VBN	p2=VBD|pb=make.05	20	partmod	_
22	on	on	IN	_	21	prep	21:AM-TMP
23	May	may	NNP	_	22	pobj	_
24	2	0	CD	_	26	hmod	_
25	-	-	HYPH	p2=:	26	hyph	_
26	worth	worth	JJ	p2=NN	23	num	_
27	50	0	CD	_	28	num	_
28	pounds	pound	NNS	p2=VBZ	12	appos	38:A1=PPT
29	a	a	DT	_	30	det	_
30	share	share	NN	_	28	npadvmod	_
31	at	at	IN	_	21	prep	21:AM-TMP
32	the	the	DT	_	33	det	_
33	time	time	NN	_	31	pobj	_
34	-	-	:	p2=,	28	punct	_
35	which	which	WDT	_	38	nsubjpass	38:R-A1
36	was	be	VBD	_	38	auxpass	_
37	swiftly	swiftly	RB	_	38	advmod	38:AM-MNR
38	rejected	reject	VBN	pb=reject.01	28	rcmod	_
39	by	by	IN	_	38	agent	38:A0=PAG
40	AstraZeneca	astrazeneca	NNP	_	39	pobj	_
41	.	.	.	_	4	punct	_

1	Nonetheless	nonetheless	RB	_	18	advmod	18:AM-DIS
2	,	,	,	_	18	punct	_
3	two	#crd#	CD	_	4	num	_
4	analysts	analyst	NNS	_	6	hmod	_
5	-	-	HYPH	p2=:	6	hyph	_
6	Raghuram	raghuram	NNP	_	7	nn	_
7	Selvaraju	selvaraju	NNP	_	18	nsubj	18:A0
8	of	of	IN	_	7	prep	_
9	Aegis	aegis	NNP	_	10	nn	_
10	Capital	capital	NNP	_	8	pobj	_
11	and	and	CC	_	10	cc	_
12	ISI	isi	NNP	_	13	nn	_
13	Group	group	NNP	_	18	nsubj	_
14	's	's	POS	_	13	possessive	_
15	Mark	mark	NNP	_	16	nn	_
16	Schoenebaum	schoenebaum	NNP	_	18	nsubj	_
17	-	-	HYPH	p2=:	18	punct	_
18	said	say	VBD	p2=VBN|pb=say.01	0	root	_
19	they	they	PRP	_	20	nsubj	20:A0=PAG
20	believed	believe	VBD	pb=believe.01	18	ccomp	18:A1=PPT
21	the	the	DT	_	23	det	_
22	sweetened	sweeten	VBN	p2=JJ|pb=sweeten.02	23	amod	_
23	offer	offer	NN	_	25	nsubj	25:A0=PAG;22:A1=PPT
24	would	would	MD	_	25	aux	25:AM-MOD
25	boost	boost	VB	pb=boost.01	20	ccomp	20:A1=PPT
26	Pfizer	pfizer	NNP	_	28	poss	_
27	's	's	POS	_	26	possessive	_
28	earnings	earnings	NNS	_	25	dobj	25:A1=PPT
29	quickly	quickly	RB	_	25	advmod	25:AM-MNR
30	,	,	,	_	25	punct	_
31	with	with	IN	_	25	prep	_
32	Schoenebaum	schoenebaum	NNP	p2=NNPS	33	nsubj	33:A0=CAU
33	predicting	predict	VBG	pb=predict.01	31	pcomp	_
34	an	an	DT	_	35	det	_
35	uplift	uplift	NN	_	33	dobj	33:A1=PPT
36	from	from	IN	_	33	prep	33:AM-TMP
37	2015	0	CD	_	36	pobj	_
38	.	.	.	_	18	punct	_

1	Pfizer	pfizer	NNP	_	3	nsubj	3:A0
2	also	also	RB	_	3	advmod	3:AM-ADV
3	revealed	reveal	VBD	pb=reveal.01	0	root	_
4	it	it	PRP	_	6	nsubj	6:A0=PAG;14:A0=PAG
5	had	have	VBD	_	6	aux	_
6	written	write	VBN	pb=write.01	3	ccomp	3:A1=PPT
7	to	to	IN	_	6	prep	6:A2=GOL
8	AstraZeneca	astrazeneca	NNP	_	10	poss	_
9	's	's	POS	_	8	possessive	_
10	chairman	chairman	NN	_	7	pobj	_
11	on	on	IN	_	6	prep	6:AM-TMP
12	May	may	NNP	_	11	pobj	_
13	16	0	CD	_	12	num	_
14	offering	offer	VBG	p2=NN|pb=offer.01	6	advcl	6:AM-ADV
15	53.50	0	CD	_	16	num	_
16	pounds	pound	NNS	_	14	iobj	14:A3=GOL
17	a	a	DT	_	21	det	_
18	share	share	NN	_	20	hmod	_
19	-	-	HYPH	p2=:	20	hyph	_
20	40	0	CD	_	21	num	_
21	%	%	NN	_	14	dobj	14:A1=PPT
22	in	in	IN	_	21	prep	_
23	cash	cash	NN	_	22	pobj	_
24	-	-	,	p2=HYPH	6	punct	_
25	but	but	CC	_	6	cc	_
26	had	have	VBD	_	28	aux	_
27	been	be	VBN	_	28	auxpass	_
28	told	tell	VBN	pb=tell.01	6	conj	_
29	that	that	IN	_	33	complm	_
30	this	this	DT	_	33	nsubj	33:A0=PAG
31	still	still	RB	_	33	advmod	33:AM-TMP
32	substantially	substantially	RB	_	33	advmod	33:AM-MNR
33	undervalued	undervalue	VBD	p2=VBN|pb=undervalue.01	28	ccomp	28:A1=PPT
34	the	the	DT	_	35	det	_
35	company	company	NN	_	33	dobj	33:A1=PPT
36	,	,	,	_	28	punct	_
37	prompting	prompt	VBG	pb=prompt.02	28	advcl	28:AM-ADV
38	it	it	PRP	_	37	dobj	40:A0=PAG;37:A1=PPT
39	to	to	TO	_	40	aux	_
40	make	make	VB	pb=make.01	37	xcomp	37:A2=PRD
41	the	the	DT	_	46	det	_
42	latest	late	JJS	_	46	amod	_
43	last	last	JJ	p2=VBN	45	hmod	_
44	-	-	HYPH	p2=:	45	hyph	_
45	ditch	ditch	NN	_	46	nn	_
46	offer	offer	NN	_	40	dobj	40:AM-PRR
47	.	.	.	_	3	punct	_

1	"	"	``	_	34	punct	_
2	We	we	PRP	_	3	nsubj	3:A0=PAG
3	believe	believe	VBP	pb=believe.01	34	ccomp	34:A1=PPT
4	our	our	PRP$	_	5	poss	_
5	proposal	proposal	NN	_	6	nsubj	6:A1=PPT
6	is	be	VBZ	pb=be.01	3	ccomp	3:A1=PPT
7	compelling	compelling	JJ	p2=VBG	6	acomp	6:A2=PRD
8	for	for	IN	_	7	prep	_
9	AstraZeneca	astrazeneca	NNP	_	11	poss	_
10	's	's	POS	_	9	possessive	_
11	shareholders	shareholder	NNS	_	8	pobj	_
12	and	and	CC	_	6	cc	_
13	that	that	IN	_	19	mark	_
14	a	a	DT	_	18	det	_
15	Pfizer	pfizer	NNP	p2=NN	17	hmod	_
16	-	-	HYPH	_	17	hyph	_
17	AstraZeneca	astrazeneca	NNP	_	18	nn	_
18	combination	combination	NN	_	19	nsubj	19:A1=PPT
19	is	be	VBZ	pb=be.01	6	conj	_
20	in	in	IN	p2=RB	19	prep	19:A2=PRD
21	the	the	DT	_	23	det	_
22	best	good	JJS	_	23	amod	_
23	interests	interest	NNS	_	20	pobj	_
24	of	of	IN	_	23	prep	_
25	all	all	DT	_	26	det	_
26	stakeholders	stakeholder	NNS	_	24	pobj	_
27	,	,	,	_	34	punct	_
28	"	"	``	p2=''	34	punct	_
29	Pfizer	pfizer	NNP	_	31	nn	_
30	Chief	chief	NNP	_	31	nn	_
31	Executive	executive	NNP	_	33	nn	_
32	Ian	ian	NNP	_	33	nn	_
33	Read	read	NNP	_	34	nsubj	34:A0
34	said	say	VBD	pb=say.01	0	root	_
35	in	in	IN	_	34	prep	34:AM-LOC
36	a	a	DT	_	37	det	_
37	statement	statement	NN	_	35	pobj	_
38	.	.	.	_	34	punct	_

1	He	he	PRP	_	2	nsubj	2:A0=PAG;13:A0=PAG
2	expressed	express	VBD	pb=express.01	0	root	_
3	frustration	frustration	NN	_	2	dobj	2:A1=PPT
4	at	at	IN	_	2	prep	_
5	AstraZeneca	astrazeneca	NNP	_	7	poss	_
6	's	's	POS	_	5	possessive	_
7	refusal	refusal	NN	_	4	pobj	_
8	to	to	TO	_	9	aux	_
9	engage	engage	VB	pb=engage.01	7	infmod	_
10	in	in	IN	_	9	prep	9:A2=PPT
11	talks	talk	NNS	_	10	pobj	_
12	and	and	CC	_	2	cc	_
13	urged	urge	VBD	pb=urge.01	2	conj	_
14	the	the	DT	_	16	det	_
15	British	british	JJ	_	16	amod	_
16	company	company	NN	_	18	poss	_
17	's	's	POS	_	16	possessive	_
18	shareholders	shareholder	NNS	_	13	dobj	20:A0=PAG;24:A0=PAG;13:A1=PPT
19	to	to	TO	_	20	aux	_
20	pressure	pressure	VB	pb=pressure.01	13	xcomp	13:A2=PPT
21	its	its	PRP$	_	22	poss	_
22	board	board	NN	_	20	dobj	20:A1=PPT
23	to	to	TO	_	24	aux	_
24	start	start	VB	pb=start.01	20	advcl	20:A2=PRD
25	discussions	discussion	NNS	_	24	dobj	24:A1=PPT
26	.	.	.	_	2	punct	_

1	"	"	``	p2=''	32	punct	_
2	Following	follow	VBG	_	13	prep	13:AM-TMP
3	a	a	DT	_	4	det	_
4	conversation	conversation	NN	_	2	pobj	_
5	with	with	IN	_	4	prep	_
6	AstraZeneca	astrazeneca	NNP	_	5	pobj	_
7	earlier	early	RBR	_	8	advmod	_
8	today	today	NN	_	4	npadvmod	_
9	,	,	,	_	13	punct	_
10	we	we	PRP	_	13	nsubj	13:A0=PAG
11	do	do	VBP	_	13	aux	_
12	not	not	RB	_	13	neg	13:AM-NEG
13	believe	believe	VB	pb=believe.01	32	ccomp	32:A1=PPT
14	that	that	IN	_	18	complm	_
15	the	the	DT	_	17	det	_
16	AstraZeneca	astrazeneca	NNP	_	17	nn	_
17	board	board	NN	_	18	nsubj	22:A0=PAG;18:A1=PPT
18	is	be	VBZ	pb=be.01	13	ccomp	13:A1=PPT
19	currently	currently	RB	_	18	advmod	18:AM-TMP
20	prepared	prepared	JJ	p2=VBN	18	acomp	18:A2=PRD
21	to	to	TO	_	22	aux	_
22	recommend	recommend	VB	pb=recommend.01	20	xcomp	_
23	a	a	DT	_	24	det	_
24	deal	deal	NN	_	22	dobj	22:A1=PPT
25	at	at	IN	_	22	prep	22:A3=PRD
26	a	a	DT	_	28	det	_
27	reasonable	reasonable	JJ	_	28	amod	_
28	price	price	NN	_	25	pobj	_
29	,	,	,	_	32	punct	_
30	"	"	''	_	32	punct	_
31	Read	read	NNP	p2=RB	32	nsubj	32:A0
32	said	say	VBD	pb=say.01	0	root	_
33	.	.	.	_	32	punct	_

1	"	"	``	_	3	punct	_
2	We	we	PRP	_	3	nsubj	6:A0=PAG;3:A1=PPT
3	remain	remain	VBP	pb=remain.01	0	root	_
4	ready	ready	JJ	_	3	acomp	3:A3=PRD
5	to	to	TO	_	6	aux	_
6	engage	engage	VB	pb=engage.01	4	xcomp	_
7	in	in	IN	_	6	prep	6:A2=PPT
8	a	a	DT	_	10	det	_
9	meaningful	meaningful	JJ	_	10	amod	_
10	dialogue	dialogue	NN	_	7	pobj	_
11	but	but	CC	p2=IN	3	cc	_
12	time	time	NN	_	17	nsubj	17:A1=LOC
13	for	for	IN	_	12	prep	_
14	constructive	constructive	JJ	_	15	amod	_
15	engagement	engagement	NN	_	13	pobj	_
16	is	be	VBZ	_	17	aux	_
17	running	run	VBG	pb=run.02	3	conj	_
18	out	out	RP	_	17	prt	17:C-V
19	.	.	.	_	17	punct	_
20	"	"	''	_	17	punct	_

1	According	accord	VBG	_	10	prep	10:AM-ADV
2	to	to	IN	_	1	prep	_
3	the	the	DT	_	5	det	_
4	Financial	financial	NNP	_	5	nn	_
5	Times	times	NNP	p2=NNPS	2	pobj	_
6	,	,	,	_	10	punct	_
7	AstraZeneca	astrazeneca	NNP	_	8	nn	_
8	executives	executive	NNS	p2=VBZ	10	nsubj	10:A0=PAG
9	also	also	RB	_	10	advmod	10:AM-DIS
10	felt	feel	VBD	pb=feel.02	0	root	_
11	that	that	IN	_	13	complm	_
12	Pfizer	pfizer	NNP	_	13	nsubj	15:A0=PAG;13:A1=PAG
13	failed	fail	VBD	pb=fail.01	10	ccomp	10:A1=PPT
14	to	to	TO	_	15	aux	_
15	give	give	VB	pb=give.01	13	xcomp	13:A2=PPT
16	assurances	assurance	NNS	_	15	dobj	15:A1=PPT
17	on	on	IN	_	16	prep	_
18	other	other	JJ	_	20	amod	_
19	key	key	JJ	_	20	amod	_
20	terms	term	NNS	_	17	pobj	_
21	of	of	IN	_	20	prep	_
22	a	a	DT	_	23	det	_
23	deal	deal	NN	_	21	pobj	_
24	,	,	,	_	20	punct	_
25	including	include	VBG	_	23	prep	_
26	commitments	commitment	NNS	_	25	pobj	_
27	to	to	IN	_	26	prep	_
28	the	the	DT	_	30	det	_
29	UK	uk	NNP	_	30	nn	_
30	group	group	NN	_	35	poss	_
31	's	's	POS	_	30	possessive	_
32	research	research	NN	_	35	nn	_
33	and	and	CC	_	32	cc	_
34	development	development	NN	_	32	conj	_
35	programs	program	NNS	_	27	pobj	_
36	.	.	.	_	10	punct	_

1	Two	#crd#	CD	_	3	num	_
2	banking	banking	NN	_	3	nn	_
3	sources	source	NNS	_	5	nsubj	5:A0=PAG
4	earlier	early	RBR	p2=JJR	5	advmod	5:AM-TMP
5	described	describe	VBD	p2=VBN|pb=describe.01	0	root	_
6	55	0	CD	_	7	num	_
7	pounds	pound	NNS	_	5	dobj	5:A1=PPT
8	a	a	DT	_	9	det	_
9	share	share	NN	_	7	npadvmod	_
10	as	as	IN	_	5	prep	5:A2=PRD
11	the	the	DT	_	14	det	_
12	"	"	``	_	14	punct	_
13	magic	magic	JJ	p2=NN	14	amod	_
14	number	number	NN	_	10	pobj	_
15	"	"	''	_	14	punct	_
16	at	at	IN	_	22	prep	_
17	which	which	WDT	_	16	pobj	_
18	a	a	DT	_	19	det	_
19	deal	deal	NN	_	22	nsubjpass	21:A1=PPT;22:A1=PPT
20	could	could	MD	_	22	aux	21:AM-MOD;22:AM-MOD
21	get	get	VB	pb=get.03	22	auxpass	_
22	done	do	VBN	pb=do.02	14	rcmod	21:A2=GOL
23	and	and	CC	_	22	cc	_
24	Selvaraju	selvaraju	NNP	p2=NN	27	nsubj	27:A0
25	of	of	IN	_	24	prep	_
26	Aegis	aegis	NNP	_	25	pobj	_
27	said	say	VBD	pb=say.01	22	conj	_
28	Pfizer	pfizer	NNP	_	30	poss	_
29	's	's	POS	_	28	possessive	_
30	declaration	declaration	NN	_	39	nsubj	39:A0=PPT
31	that	that	IN	_	34	complm	_
32	its	its	PRP$	_	33	poss	_
33	offer	offer	NN	_	34	nsubj	34:A1=PPT
34	was	be	VBD	pb=be.01	30	ccomp	_
35	"	"	``	_	36	punct	_
36	final	final	JJ	_	34	acomp	34:A2=PRD
37	"	"	''	_	34	punct	_
38	would	would	MD	_	39	aux	39:AM-MOD
39	concentrate	concentrate	VB	pb=concentrate.01	27	ccomp	27:A1=PPT
40	minds	mind	NNS	_	39	dobj	39:A1=PPT
41	at	at	IN	_	39	prep	39:AM-LOC
42	AstraZeneca	astrazeneca	NNP	_	41	pobj	_
43	.	.	.	_	5	punct	_

1	"	"	``	_	14	punct	_
2	The	the	DT	_	4	det	_
3	main	main	JJ	_	4	amod	_
4	thing	thing	NN	_	14	nsubj	7:A1=PPT;14:A1=PPT
5	that	that	WDT	_	7	nsubj	10:R-A0;7:R-A1
6	will	will	MD	_	7	aux	7:AM-MOD
7	be	be	VB	pb=be.01	4	rcmod	_
8	likely	likely	JJ	_	7	acomp	7:A2=PRD
9	to	to	TO	_	10	aux	_
10	get	get	VB	pb=get.06	8	xcomp	_
11	AstraZeneca	astrazeneca	NNP	_	13	nsubj	13:A0=PAG
12	to	to	TO	_	13	aux	_
13	engage	engage	VB	pb=engage.01	10	ccomp	10:A1=PRD
14	is	be	VBZ	pb=be.01	36	ccomp	36:A1=PPT
15	that	that	IN	p2=DT	27	complm	_
16	Ian	ian	NNP	_	17	nn	_
17	Read	read	NNP	_	27	nsubj	27:A0;20:A1=PPT
18	,	,	,	_	17	punct	_
19	who	who	WP	_	20	nsubj	20:R-A1
20	is	be	VBZ	pb=be.01	17	rcmod	_
21	a	a	DT	_	23	det	_
22	tough	tough	JJ	_	23	amod	_
23	guy	guy	NN	_	20	attr	20:A2=PRD
24	,	,	,	_	27	punct	_
25	has	have	VBZ	_	27	aux	_
26	basically	basically	RB	_	27	advmod	27:AM-ADV
27	said	say	VBN	pb=say.01	14	ccomp	14:A2=PRD
28	this	this	DT	_	29	nsubj	29:A1=PPT
29	is	be	VBZ	pb=be.01	27	ccomp	27:A1=PPT
30	our	our	PRP$	_	32	poss	_
31	final	final	JJ	_	32	amod	_
32	offer	offer	NN	_	29	attr	29:A2=PRD
33	,	,	,	_	36	punct	_
34	"	"	''	_	36	punct	_
35	he	he	PRP	_	36	nsubj	36:A0
36	said	say	VBD	pb=say.01	0	root	_
37	.	.	.	_	36	punct	_

1	In	in	IN	_	27	prep	27:AM-LOC
2	the	the	DT	_	3	det	_
3	absence	absence	NN	_	1	pobj	_
4	of	of	IN	_	3	prep	_
5	further	far	JJ	_	6	amod	_
6	discussions	discussion	NNS	_	4	pobj	_
7	or	or	CC	_	6	cc	_
8	an	an	DT	_	9	det	_
9	extension	extension	NN	_	6	conj	_
10	of	of	IN	_	9	prep	_
11	the	the	DT	_	12	det	_
12	deadline	deadline	NN	_	10	pobj	_
13	for	for	IN	_	12	prep	_
14	making	make	VBG	pb=make.LV	13	pcomp	_
15	a	a	DT	_	17	det	_
16	firm	firm	JJ	p2=NN	17	amod	_
17	offer	offer	NN	_	14	dobj	14:AM-PRR
18	under	under	IN	_	17	prep	_
19	British	british	JJ	_	21	amod	_
20	takeover	takeover	NN	_	21	nn	_
21	rules	rule	NNS	_	18	pobj	_
22	,	,	,	_	27	punct	_
23	Pfizer	pfizer	NNP	_	25	poss	_
24	's	's	POS	_	23	possessive	_
25	proposal	proposal	NN	_	27	nsubj	27:A1=PPT
26	will	will	MD	_	27	aux	27:AM-MOD
27	expire	expire	VB	pb=expire.01	0	root	_
28	at	at	IN	_	27	prep	27:AM-TMP
29	5	0	CD	_	30	num	_
30	p.m.	p.m.	NN	p2=RB	28	pobj	_
31	London	london	NNP	p2=JJ	32	nn	_
32	time	time	NN	_	30	appos	_
33	on	on	IN	_	27	prep	27:AM-TMP
34	May	may	NNP	_	33	pobj	_
35	26	0	CD	_	34	num	_
36	.	.	.	_	27	punct	_

1	An	an	DT	_	3	det	_
2	AstraZeneca	astrazeneca	NNP	_	3	nn	_
3	spokeswoman	spokeswoman	NN	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	she	she	PRP	_	6	nsubj	6:A0=PAG
6	had	have	VBD	pb=have.03	4	ccomp	4:A1=PPT
7	no	no	DT	p2=UH	9	det	_
8	immediate	immediate	JJ	_	9	amod	_
9	comment	comment	NN	_	6	dobj	6:A1=PPT
10	on	on	IN	_	9	prep	_
11	Pfizer	pfizer	NNP	_	14	poss	_
12	's	's	POS	_	11	possessive	_
13	latest	late	JJS	_	14	amod	_
14	proposal	proposal	NN	_	10	pobj	18:A0
15	,	,	,	_	14	punct	_
16	which	which	WDT	_	18	nsubj	18:R-A0
17	would	would	MD	_	18	aux	18:AM-MOD
18	see	see	VB	pb=see.01	14	rcmod	_
19	Pfizer	pfizer	NNP	p2=NN	20	nn	_
20	shareholders	shareholder	NNS	_	21	nsubj	21:A0=PAG
21	owning	own	VBG	pb=own.01	18	ccomp	18:A1
22	74	0	CD	_	23	num	_
23	%	%	NN	_	21	dobj	21:A1=PPT
24	of	of	IN	_	23	prep	_
25	the	the	DT	_	27	det	_
26	combined	combine	VBN	p2=JJ|pb=combine.01	27	amod	_
27	company	company	NN	_	24	pobj	26:A1=PPT
28	,	,	,	_	21	punct	_
29	with	with	IN	_	21	prep	_
30	AstraZeneca	astrazeneca	NNP	p2=JJ	31	nn	_
31	shareholders	shareholder	NNS	_	32	nsubj	32:A0=PAG
32	holding	hold	VBG	pb=hold.01	29	pcomp	_
33	26	0	CD	_	34	num	_
34	%	%	NN	_	32	dobj	32:A1=PPT
35	.	.	.	_	4	punct	_

1	The	the	DT	_	3	det	_
2	increased	increase	VBN	p2=VBD|pb=increase.01	3	amod	_
3	offer	offer	NN	_	7	nsubjpass	2:A1=PPT;7:A1=PPT
4	had	have	VBD	_	7	aux	_
5	been	be	VBN	_	7	auxpass	_
6	widely	widely	RB	_	7	advmod	7:AM-MNR
7	expected	expect	VBN	pb=expect.01	0	root	_
8	.	.	.	_	7	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0
2	said	say	VBD	pb=say.01	0	root	_
3	last	last	JJ	_	4	amod	_
4	week	week	NN	_	2	npadvmod	2:AM-TMP
5	it	it	PRP	_	7	nsubj	7:A0=PAG
6	would	would	MD	_	7	aux	7:AM-MOD
7	consider	consider	VB	pb=consider.01	2	ccomp	2:A1=PPT
8	a	a	DT	_	10	det	_
9	higher	high	JJR	_	10	amod	_
10	offer	offer	NN	_	7	dobj	7:A1
11	as	as	IN	_	13	mark	_
12	it	it	PRP	_	13	nsubj	13:A0=PAG
13	urged	urge	VBD	pb=urge.01	7	advcl	7:AM-TMP
14	AstraZeneca	astrazeneca	NNP	_	16	poss	_
15	's	's	POS	_	14	possessive	_
16	board	board	NN	_	13	dobj	18:A0=PPT;13:A1=PPT
17	to	to	TO	_	18	aux	_
18	enter	enter	VB	pb=enter.01	13	xcomp	13:A2=PPT
19	talks	talk	NNS	_	18	dobj	18:A1=LOC
20	.	.	.	_	2	punct	_

1	The	the	DT	_	3	det	_
2	British	british	JJ	_	3	amod	_
3	firm	firm	NN	_	5	nsubj	5:A0=PAG;15:A0=PAG
4	has	have	VBZ	_	5	aux	_
5	laid	lay	VBN	pb=lay.01	0	root	_
6	out	out	RP	_	5	prt	5:C-V
7	details	detail	NNS	_	5	dobj	5:A1=PPT
8	of	of	IN	_	7	prep	_
9	its	its	PRP$	_	10	poss	_
10	pipeline	pipeline	NN	_	8	pobj	_
11	of	of	IN	_	10	prep	_
12	new	new	JJ	_	13	amod	_
13	drugs	drug	NNS	_	11	pobj	_
14	and	and	CC	_	5	cc	_
15	argues	argue	VBZ	p2=NNS|pb=argue.01	5	conj	_
16	there	there	EX	_	17	expl	_
17	is	be	VBZ	pb=be.02	15	ccomp	15:A1=PPT
18	no	no	DT	_	19	det	_
19	inevitability	inevitability	NN	_	17	attr	17:A1=PPT
20	about	about	IN	_	19	prep	_
21	a	a	DT	_	23	det	_
22	Pfizer	pfizer	NNP	_	23	nn	_
23	deal	deal	NN	_	20	pobj	_
24	,	,	,	_	17	punct	_
25	although	although	IN	_	29	mark	_
26	its	its	PRP$	_	27	poss	_
27	management	management	NN	_	29	nsubj	29:A0=PAG
28	also	also	RB	_	29	advmod	29:AM-ADV
29	acknowledges	acknowledge	VBZ	pb=acknowledge.01	17	advcl	17:AM-ADV
30	the	the	DT	_	31	det	_
31	board	board	NN	_	33	nsubj	35:A0=PAG
32	would	would	MD	_	33	aux	33:AM-MOD
33	have	have	VB	pb=have.02	29	ccomp	29:A1=PPT
34	to	to	TO	_	35	aux	_
35	consider	consider	VB	pb=consider.01	33	xcomp	_
36	a	a	DT	_	38	det	_
37	compelling	compelling	JJ	_	38	amod	_
38	bid	bid	NN	_	35	dobj	35:A1
39	.	.	.	_	5	punct	_

1	Investors	investor	NNS	_	3	nsubj	3:A0=PAG;6:A0=PAG
2	have	have	VBP	_	3	aux	_
3	backed	back	VBN	pb=back.01	0	root	_
4	AstraZeneca	astrazeneca	NNP	_	3	dobj	3:A1=PPT
5	in	in	IN	_	3	prep	3:AM-MNR
6	rejecting	reject	VBG	pb=reject.01	5	pcomp	_
7	50	0	CD	_	8	num	_
8	pounds	pound	NNS	_	6	dobj	6:A1=PPT
9	a	a	DT	_	10	det	_
10	share	share	NN	_	8	npadvmod	_
11	,	,	,	_	3	punct	_
12	but	but	CC	_	3	cc	_
13	many	many	JJ	_	15	nsubj	15:A0
14	have	have	VBP	_	15	aux	_
15	said	say	VBN	pb=say.01	3	conj	_
16	they	they	PRP	_	18	nsubj	18:A0=PAG
17	would	would	MD	_	18	aux	18:AM-MOD
18	want	want	VB	pb=want.01	15	ccomp	15:A1=PPT
19	it	it	PRP	_	21	nsubj	21:A0=PAG
20	to	to	TO	_	21	aux	_
21	engage	engage	VB	pb=engage.01	18	ccomp	18:A1=PPT
22	in	in	IN	_	21	prep	21:A2=PPT
23	discussions	discussion	NNS	_	22	pobj	_
24	if	if	IN	_	26	mark	_
25	Pfizer	pfizer	NNP	_	26	nsubj	26:A1=PPT
26	came	come	VBD	pb=come.01	18	advcl	18:AM-ADV;21:AM-ADV
27	back	back	RB	p2=RP	26	advmod	26:AM-DIR
28	with	with	IN	_	26	prep	26:AM-MNR
29	an	an	DT	_	31	det	_
30	improved	improved	JJ	p2=VBN	31	amod	_
31	offer	offer	NN	_	28	pobj	_
32	.	.	.	_	15	punct	_

1	They	they	PRP	_	2	nsubj	2:A0=PPT
2	fear	fear	VBP	pb=fear.01	0	root	_
3	AstraZeneca	astrazeneca	NNP	p2=JJ	4	nn	_
4	shares	share	NNS	_	6	nsubj	6:A1
5	will	will	MD	_	6	aux	6:AM-MOD
6	tumble	tumble	VB	pb=tumble.01	2	ccomp	2:A1=PAG
7	if	if	IN	_	9	mark	_
8	Pfizer	pfizer	NNP	_	9	nsubj	9:A0=PPT
9	walks	walk	VBZ	pb=walk.01	6	advcl	6:AM-ADV
10	away	away	RB	_	9	advmod	9:AM-DIR
11	.	.	.	_	2	punct	_

1	There	there	EX	_	3	expl	_
2	has	have	VBZ	_	3	aux	_
3	been	be	VBN	pb=be.02	0	root	_
4	a	a	DT	_	7	det	_
5	mounting	mount	VBG	p2=JJ|pb=mount.02	7	amod	_
6	political	political	JJ	_	7	amod	_
7	backlash	backlash	NN	_	3	attr	3:A1=PPT;5:A1=PPT
8	against	against	IN	_	7	prep	_
9	the	the	DT	_	11	det	_
10	proposed	propose	VBN	p2=JJ|pb=propose.01	11	amod	_
11	deal	deal	NN	_	8	pobj	10:A1=PPT
12	in	in	IN	_	11	prep	_
13	Britain	britain	NNP	_	12	pobj	_
14	,	,	,	_	13	punct	_
15	the	the	DT	_	17	det	_
16	United	united	NNP	_	17	nn	_
17	States	states	NNP	_	13	conj	_
18	and	and	CC	_	17	cc	_
19	Sweden	sweden	NNP	_	17	conj	_
20	,	,	,	_	17	punct	_
21	where	where	WRB	_	23	advmod	23:R-AM-LOC
22	AstraZeneca	astrazeneca	NNP	_	23	nsubj	23:A0=PAG
23	has	have	VBZ	pb=have.03	17	rcmod	_
24	half	half	PDT	p2=VBN	26	predet	_
25	its	its	PRP$	_	26	poss	_
26	roots	root	NNS	_	23	dobj	23:A1=PPT
27	.	.	.	_	3	punct	_

1	The	the	DT	_	3	det	_
2	Swedish	swedish	JJ	_	3	amod	_
3	government	government	NN	_	4	nsubj	4:A0=PAG
4	launched	launch	VBD	pb=launch.01	0	root	_
5	a	a	DT	_	7	det	_
6	concerted	concerted	JJ	_	7	amod	_
7	effort	effort	NN	_	4	dobj	4:A1=PPT
8	on	on	IN	_	4	prep	4:AM-TMP
9	Friday	friday	NNP	_	8	pobj	_
10	against	against	IN	_	4	prep	_
11	a	a	DT	_	12	det	_
12	merger	merger	NN	_	10	pobj	16:A0=PAG
13	it	it	PRP	_	14	nsubj	14:A0=PPT
14	fears	fear	VBZ	pb=fear.01	12	rcmod	_
15	will	will	MD	_	16	aux	16:AM-MOD
16	lead	lead	VB	pb=lead.03	14	ccomp	14:A1=PAG
17	to	to	IN	_	16	prep	16:A2=PRD
18	cuts	cut	NNS	_	17	pobj	_
19	in	in	IN	_	18	prep	_
20	science	science	NN	_	21	nn	_
21	jobs	job	NNS	_	19	pobj	_
22	and	and	CC	_	21	cc	_
23	research	research	NN	_	21	conj	_
24	,	,	,	_	18	punct	_
25	echoing	echo	VBG	pb=echo.01	26	amod	_
26	concerns	concern	NNS	_	18	conj	25:A0=PPT;27:A1=PPT
27	aired	air	VBN	pb=air.01	26	partmod	_
28	by	by	IN	_	27	agent	27:A0=PAG
29	British	british	JJ	_	30	amod	_
30	lawmakers	lawmaker	NNS	_	28	pobj	_
31	at	at	IN	_	27	prep	27:AM-LOC
32	two	#crd#	CD	_	34	num	_
33	parliamentary	parliamentary	JJ	_	34	amod	_
34	hearings	hearing	NNS	_	31	pobj	_
35	last	last	JJ	p2=VBP	36	amod	_
36	week	week	NN	_	27	npadvmod	27:AM-TMP
37	and	and	CC	_	26	cc	_
38	fears	fear	NNS	p2=VBZ	26	conj	_
39	for	for	IN	_	38	prep	_
40	US	us	NNP	_	41	nn	_
41	jobs	job	NNS	_	39	pobj	_
42	in	in	IN	_	41	prep	_
43	states	state	NNS	_	42	pobj	46:AM-LOC
44	where	where	WRB	_	46	advmod	46:R-AM-LOC
45	AstraZeneca	astrazeneca	NNP	_	46	nsubj	46:A0=PAG
46	has	have	VBZ	pb=have.03	43	rcmod	_
47	a	a	DT	_	49	det	_
48	large	large	JJ	_	49	amod	_
49	presence	presence	NN	_	46	dobj	46:A1=PPT
50	.	.	.	_	4	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	poss	_
2	's	's	POS	_	1	possessive	_
3	bid	bid	NN	_	5	nsubj	5:A1=PPT
4	would	would	MD	_	5	aux	5:AM-MOD
5	be	be	VB	pb=be.01	0	root	_
6	the	the	DT	_	9	det	_
7	largest	large	JJS	_	9	amod	_
8	foreign	foreign	JJ	_	9	amod	_
9	takeover	takeover	NN	_	5	attr	5:A2=PRD
10	of	of	IN	_	9	prep	_
11	a	a	DT	_	13	det	_
12	British	british	JJ	_	13	amod	_
13	firm	firm	NN	_	10	pobj	_
14	and	and	CC	_	5	cc	_
15	is	be	VBZ	_	16	auxpass	_
16	opposed	oppose	VBN	pb=oppose.01	5	conj	_
17	by	by	IN	_	16	agent	16:A0=PPT
18	many	many	JJ	_	19	amod	_
19	scientists	scientist	NNS	_	17	pobj	23:A0=PPT
20	and	and	CC	_	19	cc	_
21	politicians	politician	NNS	_	19	conj	_
22	who	who	WP	p2=TO	23	nsubj	23:R-A0
23	fear	fear	VBP	pb=fear.01	19	rcmod	_
24	it	it	PRP	_	26	nsubj	26:A0=PAG
25	will	will	MD	_	26	aux	26:AM-MOD
26	undermine	undermine	VB	pb=undermine.01	23	ccomp	23:A1=PAG
27	Britain	britain	NNP	_	30	poss	_
28	's	's	POS	_	27	possessive	_
29	science	science	NN	_	30	nn	_
30	base	base	NN	_	26	dobj	26:A1=PPT
31	.	.	.	_	5	punct	_

1	British	british	JJ	_	3	amod	_
2	Prime	prime	NNP	_	3	nn	_
3	Minister	minister	NNP	_	5	nn	_
4	David	david	NNP	_	5	nn	_
5	Cameron	cameron	NNP	_	7	nsubj	7:A0
6	has	have	VBZ	_	7	aux	_
7	said	say	VBN	p2=VBD|pb=say.01	0	root	_
8	he	he	PRP	_	9	nsubj	9:A0=PAG
9	wants	want	VBZ	pb=want.01	7	ccomp	7:A1=PPT
10	more	more	JJR	_	11	amod	_
11	assurances	assurance	NNS	_	9	dobj	9:A1=PPT
12	from	from	IN	_	11	prep	_
13	Pfizer	pfizer	NNP	_	12	pobj	_
14	,	,	,	_	9	punct	_
15	and	and	CC	_	9	cc	_
16	science	science	NN	_	17	nn	_
17	minister	minister	NN	_	19	nn	_
18	David	david	NNP	_	19	nn	_
19	Willetts	willetts	NNP	_	20	nsubj	20:A0
20	said	say	VBD	pb=say.01	9	conj	_
21	last	last	JJ	_	22	amod	_
22	week	week	NN	_	20	npadvmod	20:AM-TMP
23	he	he	PRP	_	25	nsubj	25:A0=PAG;27:A0
24	would	would	MD	_	25	aux	25:AM-MOD
25	like	like	VB	pb=like.02	20	ccomp	20:A1=PPT
26	to	to	TO	_	27	aux	_
27	see	see	VB	pb=see.01	25	xcomp	25:A1=PPT
28	longer	long	JJR	p2=RB	29	amod	_
29	guarantees	guarantee	NNS	_	27	dobj	27:A1
30	on	on	IN	_	29	prep	_
31	investment	investment	NN	_	30	pobj	_
32	than	than	IN	_	31	prep	_
33	the	the	DT	_	35	det	_
34	five	#crd#	CD	_	35	num	_
35	years	year	NNS	_	32	pobj	37:A1=GOL
36	currently	currently	RB	_	37	advmod	37:AM-TMP
37	promised	promise	VBN	p2=VBD|pb=promise.01	35	partmod	_
38	by	by	IN	_	37	agent	37:A0=PAG
39	Pfizer	pfizer	NNP	_	38	pobj	_
40	.	.	.	_	20	punct	_

1	The	the	DT	_	3	det	_
2	UK	uk	NNP	_	3	nn	_
3	government	government	NN	_	5	nsubj	5:A0=PAG
4	has	have	VBZ	_	5	aux	_
5	held	hold	VBN	pb=hold.04	0	root	_
6	exploratory	exploratory	JJ	_	7	amod	_
7	discussions	discussion	NNS	_	5	dobj	5:A1=PPT
8	with	with	IN	_	7	prep	_
9	Brussels	brussels	NNP	p2=NNPS	8	pobj	_
10	about	about	IN	_	7	prep	_
11	strengthening	strengthen	VBG	pb=strengthen.01	10	pcomp	_
12	its	its	PRP$	_	13	poss	_
13	ability	ability	NN	_	11	dobj	11:A1=PPT
14	to	to	TO	_	15	aux	_
15	force	force	VB	pb=force.01	13	infmod	_
16	Pfizer	pfizer	NNP	p2=NN	15	dobj	18:A0;15:A1=PPT
17	to	to	TO	p2=IN	18	aux	_
18	honour	honour	VB	pb=honor.01	15	xcomp	15:A2=PRD
19	commitments	commitment	NNS	_	18	dobj	18:A1
20	on	on	IN	_	19	prep	_
21	jobs	job	NNS	_	20	pobj	_
22	and	and	CC	_	21	cc	_
23	research	research	NN	_	21	conj	_
24	under	under	IN	_	21	prep	_
25	European	european	NNP	_	26	nn	_
26	Union	union	NNP	_	27	nn	_
27	rules	rule	NNS	p2=VBZ	24	pobj	_
28	.	.	.	_	5	punct	_

1	But	but	CC	_	15	cc	15:AM-DIS
2	Cameron	cameron	NNP	_	15	nsubj	15:A0
3	,	,	,	_	2	punct	_
4	head	head	NN	_	2	appos	_
5	of	of	IN	_	4	prep	_
6	the	the	DT	_	11	det	_
7	free	free	JJ	_	9	hmod	_
8	-	-	HYPH	_	9	hyph	_
9	market	market	NN	_	11	nn	_
10	Conservative	conservative	NNP	p2=JJ	11	nn	_
11	Party	party	NNP	_	5	pobj	_
12	,	,	,	_	15	punct	_
13	has	have	VBZ	_	15	aux	_
14	also	also	RB	_	15	advmod	15:AM-DIS
15	said	say	VBN	pb=say.01	0	root	_
16	Britain	britain	NNP	_	19	nsubj	19:A0=PAG;25:A0=PAG;22:A1
17	does	do	VBZ	_	19	aux	_
18	not	not	RB	_	19	neg	19:AM-NEG
19	want	want	VB	pb=want.01	15	ccomp	15:A1=PPT
20	to	to	TO	_	22	aux	_
21	be	be	VB	_	22	auxpass	_
22	seen	see	VBN	pb=see.01	19	xcomp	19:A1=PPT
23	to	to	TO	_	25	aux	_
24	be	be	VB	_	25	aux	_
25	pulling	pull	VBG	pb=pull.01	22	xcomp	22:C-A1
26	up	up	RP	p2=IN	25	prt	25:A2=DIR
27	the	the	DT	_	28	det	_
28	drawbridge	drawbridge	NN	_	25	dobj	25:A1=PPT
29	to	to	IN	_	28	prep	_
30	foreign	foreign	JJ	_	31	amod	_
31	companies	company	NNS	_	29	pobj	_
32	.	.	.	_	15	punct	_

1	Although	although	IN	_	4	mark	_
2	Pfizer	pfizer	NNP	_	4	nsubj	4:A0=PAG
3	has	have	VBZ	_	4	aux	_
4	given	give	VBN	pb=give.01	20	advcl	20:AM-ADV;27:AM-ADV
5	a	a	DT	_	9	det	_
6	five	#crd#	CD	_	8	hmod	_
7	-	-	HYPH	_	8	hyph	_
8	year	year	NN	_	9	nn	_
9	commitment	commitment	NN	_	4	dobj	4:A1=PPT
10	to	to	IN	p2=TO	11	aux	_
11	complete	complete	JJ	p2=VB	9	infmod	_
12	AstraZeneca	astrazeneca	NNP	_	16	poss	_
13	's	's	POS	_	12	possessive	_
14	new	new	JJ	_	16	amod	_
15	research	research	NN	_	16	nn	_
16	centre	centre	NN	_	11	dobj	_
17	in	in	IN	_	11	prep	_
18	Cambridge	cambridge	NNP	_	17	pobj	_
19	,	,	,	_	20	punct	_
20	retain	retain	VB	p2=VBP|pb=retain.01	39	ccomp	_
21	a	a	DT	_	22	det	_
22	factory	factory	NN	_	20	dobj	20:A1=PPT
23	in	in	IN	_	22	prep	_
24	northern	northern	JJ	_	25	amod	_
25	England	england	NNP	_	23	pobj	_
26	and	and	CC	_	20	cc	_
27	put	put	VB	p2=VBD|pb=put.01	20	conj	_
28	a	a	DT	_	29	det	_
29	fifth	#ord#	NN	p2=JJ	27	dobj	27:A1=PPT
30	of	of	IN	_	29	prep	_
31	its	its	PRP$	_	33	poss	_
32	research	research	NN	_	33	nn	_
33	staff	staff	NN	_	30	pobj	_
34	in	in	IN	_	27	prep	27:A2=GOL
35	Britain	britain	NNP	_	34	pobj	_
36	,	,	,	_	39	punct	_
37	it	it	PRP	_	39	nsubj	39:A0
38	has	have	VBZ	_	39	aux	_
39	said	say	VBN	p2=VBD|pb=say.01	0	root	_
40	this	this	DT	_	43	nsubjpass	43:A1=PPT
41	could	could	MD	_	43	aux	43:AM-MOD
42	be	be	VB	_	43	auxpass	_
43	adjusted	adjust	VBN	pb=adjust.01	39	ccomp	39:A1=PPT
44	if	if	IN	_	46	mark	_
45	circumstances	circumstance	NNS	_	46	nsubj	46:A1=PPT
46	change	change	VBP	p2=NN|pb=change.01	43	advcl	43:AM-ADV
47	"	"	``	_	48	punct	_
48	significantly	significantly	RB	_	46	advmod	46:AM-MNR
49	"	"	''	_	39	punct	_
50	.	.	.	_	39	punct	_

1	Pfizer	pfizer	NNP	p2=NN	3	poss	_
2	's	's	POS	_	1	possessive	_
3	Read	read	NNP	_	4	nsubj	4:A0
4	said	say	VBD	pb=say.01	0	root	_
5	on	on	IN	_	4	prep	4:AM-TMP
6	Sunday	sunday	NNP	_	5	pobj	_
7	:	:	:	_	4	punct	_
8	"	"	``	_	4	punct	_
9	We	we	PRP	_	10	nsubj	10:A1=PPT
10	stand	stand	VBP	pb=stand.01	4	ccomp	4:A1=PPT
11	by	by	IN	_	10	prep	10:A2=LOC
12	our	our	PRP$	_	14	poss	_
13	unprecedented	unprecedented	JJ	_	14	amod	_
14	commitments	commitment	NNS	_	11	pobj	_
15	to	to	IN	_	14	prep	_
16	the	the	DT	_	18	det	_
17	UK	uk	NNP	_	18	nn	_
18	government	government	NN	_	15	pobj	_
19	.	.	.	_	4	punct	_
20	"	"	''	_	4	punct	_

1	The	the	DT	_	3	det	_
2	tax	tax	NN	_	3	nn	_
3	aspects	aspect	NNS	_	11	nsubj	11:A0=CAU
4	of	of	IN	_	3	prep	_
5	the	the	DT	_	6	det	_
6	deal	deal	NN	_	4	pobj	_
7	,	,	,	_	11	punct	_
8	meanwhile	meanwhile	RB	_	11	advmod	11:AM-TMP
9	,	,	,	_	11	punct	_
10	have	have	VBP	_	11	aux	_
11	sparked	spark	VBN	pb=spark.01	0	root	_
12	anger	anger	NN	_	11	dobj	11:A1=PPT
13	in	in	IN	_	11	prep	_
14	the	the	DT	_	16	det	_
15	United	united	NNP	_	16	nn	_
16	States	states	NNP	_	13	pobj	_
17	,	,	,	_	16	punct	_
18	where	where	WRB	_	22	advmod	22:R-AM-LOC
19	lawmakers	lawmaker	NNS	_	22	nsubj	22:A0=PAG
20	are	be	VBP	_	22	aux	_
21	now	now	RB	_	22	advmod	22:AM-TMP
22	considering	consider	VBG	pb=consider.02	16	rcmod	_
23	legislation	legislation	NN	_	22	dobj	25:A0=PAG;22:A1=PPT
24	to	to	TO	_	25	aux	_
25	prevent	prevent	VB	pb=prevent.01	23	infmod	_
26	so	so	RB	_	28	hmod	_
27	-	-	HYPH	_	28	hyph	_
28	called	call	VBN	_	30	amod	_
29	corporate	corporate	JJ	_	30	amod	_
30	inversions	inversion	NNS	_	25	dobj	25:A1=PPT;36:A1
31	,	,	,	_	30	punct	_
32	under	under	IN	_	36	prep	36:R-AM-LOC
33	which	which	WDT	_	32	pobj	_
34	US	us	NNP	_	35	nn	_
35	companies	company	NNS	p2=VBZ	36	nsubj	36:A0;39:A0=PAG
36	re-incorporate	re-incorporate	VBP	p2=JJ|pb=re-incorporate.01	30	rcmod	_
37	overseas	overseas	RB	p2=JJ	36	advmod	36:AM-LOC
38	to	to	TO	_	39	aux	_
39	avoid	avoid	VB	pb=avoid.01	36	advcl	36:AM-PRP
40	US	us	NNP	_	41	nn	_
41	taxes	tax	NNS	_	39	dobj	39:A1=PPT
42	.	.	.	_	11	punct	_

1	Inversions	inversion	NNS	_	3	nsubj	3:A0=PAG;4:A2=PPT
2	have	have	VBP	_	3	aux	_
3	helped	help	VBN	p2=VBD|pb=help.01	0	root	_
4	fuel	fuel	VB	p2=NN|pb=fuel.01	3	xcomp	3:A1=PPT
5	a	a	DT	_	6	det	_
6	wave	wave	NN	_	4	dobj	4:A1=GOL
7	of	of	IN	_	6	prep	_
8	deals	deal	NNS	_	7	pobj	_
9	in	in	IN	_	8	prep	_
10	the	the	DT	_	12	det	_
11	pharmaceuticals	pharmaceutical	NNS	_	12	nn	_
12	sector	sector	NN	_	9	pobj	_
13	in	in	IN	_	6	prep	_
14	recent	recent	JJ	_	15	amod	_
15	months	month	NNS	_	13	pobj	_
16	,	,	,	_	3	punct	_
17	but	but	CC	_	3	cc	_
18	buying	buy	VBG	p2=NN|pb=buy.01	21	csubj	21:A0=PAG
19	AstraZeneca	astrazeneca	NNP	_	18	dobj	18:A1=PPT
20	would	would	MD	_	21	aux	21:AM-MOD
21	allow	allow	VB	pb=allow.01	3	conj	_
22	Pfizer	pfizer	NNP	_	24	nsubj	24:A0=PAG
23	to	to	TO	_	24	aux	_
24	carry	carry	VB	pb=carry.03	21	ccomp	21:A1=PPT
25	out	out	RP	_	24	prt	24:C-V
26	the	the	DT	_	29	det	_
27	largest	large	JJS	_	29	amod	_
28	such	such	JJ	_	29	amod	_
29	deal	deal	NN	_	24	dobj	24:A1=PPT
30	yet	yet	RB	_	24	advmod	24:AM-TMP
31	.	.	.	_	21	punct	_

